Showing results (411-420 of 674) with videos related to

Sort By:
Pageof 68
Intestinal Research|November 19, 2020
Effect of resistance exercise training on Crohn's disease patientsKonstantinos Papadimitriou
Intestinal Research|February 25, 2020
Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entityRamit Mahajan, Yogesh Gupta, Arshdeep Singh, et al.
Intestinal Research|July 9, 2020
Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn's diseaseHiroyuki Okamoto, Nathanael L Dirks, Maria Rosario, et al.
Intestinal Research|April 19, 2023
Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?Emiko Mizoguchi, Takayuki Sadanaga, Toshiyuki Okada, et al.
Intestinal Research|November 8, 2023
Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based studyEun Hye Oh, Ye-Jee Kim, Minju Kim, et al.
Intestinal Research|May 21, 2024
Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort studyKijae Jo, Kwang Woo Kim, Hyun Jung Lee, et al.
Intestinal Research|January 26, 2019
Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatientsMarcello Rabello Imbrizi, Daniela Oliveira Magro, Tirzah de Mendonça Lopes Secundo, et al.
Intestinal Research|February 2, 2019
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn's disease?: a systematic reviewEbby George Simon, Richard Wardle, Aye Aye Thi, et al.
Intestinal Research|February 2, 2019
Is stool frequency associated with the richness and community composition of gut microbiota?Hye Jung Kwon, Jong Hyun Lim, Dongmin Kang, et al.
Intestinal Research|December 4, 2018
Long-term prognosis of Japanese patients with biologic-naïve Crohn's disease treated with anti-tumor necrosis factor-α antibodiesRintaro Moroi, Katsuya Endo, Katsutoshi Yamamoto, et al.
Pageof 68